Goldman Sachs
GEN

Goldman Sachs’s Genesis Healthcare, Inc. GEN Stock Holding History

Goldman Sachs’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100,000
Closed -$613K – 7451
2015
Q3 		$613K Hold
100,000
– – ﹤0.01% 4939
2015
Q2 		$660K Buy
+100,000
New +$675K ﹤0.01% 4907

Other funds holding GEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Goldman Sachs's GEN Position: Q3 2020 in Review

Goldman Sachs sold out of Genesis Healthcare, Inc. (GEN) in Q3 2020, closing a stake of 130,342 shares — an estimated $90K sold.

Goldman Sachs first reported a position in GEN in Q1 2015 and held it in 20 quarters. The position peaked at $1.5M in Q1 2015. 55 funds tracked by Wall St. Rank hold GEN as of Q3 2020.

  • Goldman Sachs reported no remaining Genesis Healthcare, Inc. position as of Q3 2020 after selling out during the quarter.
  • Goldman Sachs sold 130,342 Genesis Healthcare, Inc. shares in Q3 2020, an estimated $90K.
  • Goldman Sachs first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 20 quarters.
  • Goldman Sachs's Genesis Healthcare, Inc. position peaked at $1.5M in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2020.

Based on Goldman Sachs's 13F filing for Q3 2020, filed 13 Nov 2020.